Navigation Links
Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
Date:6/8/2012

ies, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of June 8, 2012 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
2. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
3. Amgen to Present at the Baird Growth Stock Conference
4. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
5. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
6. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
7. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
10. ERT Announces Clearance from German Federal Cartel Office
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014  In the Friday, December 19 edition of ... Healthcare Information Technology (HIT) features Konica Minolta, the company announced today. ... with several leading healthcare organizations. In addition to ... markets, such as New York , ... , Minneapolis and San ...
(Date:12/19/2014)... Breckenridge Pharmaceutical, Inc. announced today that it ... Pvt. Ltd. ( Hyderabad, India ) under ... ANDAs.  Under the terms of the agreement, MSN will ... for the U.S. market, and Breckenridge will market and ... have agreed to develop an oral antibiotic with current ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, 2014 /PRNewswire/ ...  Sorrento), an oncology company developing new treatments for ... privately-held immuno-oncology company developing proprietary Neukoplast ® ... announced today that the companies have entered into ... CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for the treatment ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... FARMINGDALE, N.Y., March 1, 2011 Misonix, Inc. ... company that designs, manufactures, and markets innovative, therapeutic, ... neurosurgery, laparoscopic surgery, and other surgical and medical ... the ROTH Capital 23rd Annual Growth Stock Conference ...
... ERES ), a global technology-driven provider of clinical ... organizations, announced today that the Nasdaq Stock Market has ... will trade on the Nasdaq Global Select Market under ... advised to make note of this trading symbol change. ...
Cached Medicine Technology:ERT to Change Trading Symbol to "ERT" Effective March 7, 2011 to Properly Align Business Brand 2
(Date:12/21/2014)... BellasDress.com offers a wide range of women’s ... announces its BellasDress Christmas Sale , offering big ... , BellasDress is a famous online supplier of women’s ... a series of promotions. The dress experts of the ... “We are proud of offering high quality wedding dresses ...
(Date:12/21/2014)... AngelWeddingDress.com’s new collection of 2015 spring wedding dresses was ... designs in this collection, and all of them are ... promises to provide the most fashionable designs to ... fashion trends come and go. If ladies have any ... is ready to assist. , “These new models ...
(Date:12/21/2014)... Recently, one of the best prom dresses online shops ... introduced its new collection of 2015 prom dresses, and ... its prom dresses & other fashionable designs, up to ... quality dress products and great customer services to its ... the best prom dresses online shops around the world ...
(Date:12/21/2014)... 2014 Serious Buyer, Andrew Hawley from ... Morrison and the Doors International Ballroom at the Hilton ... be the only time that Morrison's mother would see ... 25, 1967. According to Hawley, “This would be the ... the Alexandria Roller Rink earlier that year and would ...
(Date:12/21/2014)... 21, 2014 SCI explores ... issues and systemic barriers for disabled athletes with ... Scheidies has a condition called juvenile macular degeneration, where ... how he adapted his athletic ambitions to his vision ... in triathlon to pioneer the way for other blind ...
Breaking Medicine News(10 mins):Health News:BellasDress.com Announces its BellasDress Christmas Sale 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3
... Commission has instituted a rule that doctors can no ... despite protests from lawyers and several doctors' groups. //Since ... misconduct by doctors and physician assistants and says that ... disciplinary action being taken. ,But the Commission ...
... out simultaneous raids on some government hospital doctors and ... Monday.// ,The raids were conducted in Chennai, Goa, ... the investigating agency said., ,The houses of Sudha ... Goel of Sucheta Kriplani Hospital here were searched, he ...
... is being tried in the Asia Pacific region, says drug ... in the US and further testing on a few hundred ... year, Dr. Hans L. Bock told the Straits Times. ... fast, given that this is an issue of major public ...
... at a leading National Health Services (NHS) trust will be moved ... to save tens of millions of pounds on hospital beds in ... 100 patients suffering from cancer or blood disorders at University College ... the Radisson Edwardian Grafton, a four-star hotel where rooms cost ?168 ...
... 350 crore to add 1,800 beds over the next 18 ... Group's total capacity would touch 7,200 beds, from the current ... 800 beds through management of hospitals and another 1,000 beds ... said here on the sidelines of India Health Summit organised ...
... U.S. Food Drug Administration (US FDA) has approved ... mg.// ,Cephalexin is used to treat many ... tonsillitis, ear infections, skin infections, and urinary tract ... obtaining the first product approval from the dedicated ...
Cached Medicine News:Health News:Hospital Cuts Costs By Moving Cancer Patients To Hotels 2
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... Through its unique and patented ... wires and trunk cables between patients ... monitors, allowing freedom of movement throughout ... technology, the LifeSync(R) System employs two-way ...
Inquire...
... STA Compact is ... access coagulation analyser for ... latex based .coagulation tests.The ... loading of primary tubes, ...
Medicine Products: